The Transitional Liver Clinic (TLC): Reducing Liver Disease Readmission

过渡肝脏诊所 (TLC):减少肝病再入院

基本信息

  • 批准号:
    10587530
  • 负责人:
  • 金额:
    $ 70.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-02-01 至 2027-11-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Individuals with liver cirrhosis and alcoholic hepatitis often experience the complications of advanced liver disease: ascites, hepatic encephalopathy, and gastrointestinal bleeding. These complications frequently lead to hospitalizations, and after hospital discharge, disease complications can interact with medication errors and poor provider communication, resulting in frequent early hospital readmissions. Outcomes during the vulnerable post-discharge transition period could be improved through better transitional care (TC), focused on optimizing treatment regimens, improving communication, and facilitating access to community and other healthcare resources. TC addressing these issues has successfully improved outcomes in heart failure and other conditions, but there are few data on TC programs in patients with advanced liver disease, who suffer from unique clinical complications that can complicate TC treatment plans. To address this gap in our healthcare delivery system, we have developed an advanced practice provider (APP)-led TC program for patients with the complications of advanced liver disease: the Transitional Liver Clinic (TLC). In the TLC, patients discharged from the hospital with complications of advanced liver disease are contacted by telephone within two days of discharge, followed by a face-to-face or video telehealth visit with the APP within 7-14 days. During this time, TLC providers reconcile and manage medications, provide education and linkage to community resources, and facilitate necessary follow-up. This proposal aims to test the effect of the TLC on hospital readmissions, quality of life, and patient satisfaction with care. The hypothesis is that the TLC will improve patient outcomes across these domains. To achieve these aims, the TLC will be evaluated using a pragmatic stepped-wedge randomized controlled trial comparing the TLC to usual care at four high-volume tertiary care liver centers. Upon completion of the study, the investigators will have provided evidence for the efficacy of TC in reducing acute healthcare utilization and in improving quality of life and patient satisfaction for those with complications of advanced liver disease.
项目总结/摘要 肝硬化和酒精性肝炎患者经常会出现晚期肝硬化的并发症。 疾病:腹水、肝性脑病和消化道出血。这些并发症经常导致 到住院,出院后,疾病并发症可能与用药错误相互作用, 提供者沟通不良,导致频繁的早期再入院。2004 - 2005年期间的成果 脆弱的出院后过渡期可以通过更好的过渡期护理(TC)得到改善,重点是 优化治疗方案,改善沟通,促进社区和其他 医疗资源。针对这些问题的TC已成功改善心力衰竭的结局, 其他条件,但很少有关于晚期肝病患者TC计划的数据, 可能使TC治疗计划复杂化的独特临床并发症。为了弥补我们在这方面的差距, 医疗保健提供系统,我们已经开发了一个先进的实践提供者(APP)主导的TC计划, 晚期肝病并发症患者:过渡性肝病诊所(TLC)。在TLC中, 通过电话联系患有晚期肝病并发症的出院患者 出院后两天内,随后在7 - 14天内通过APP进行面对面或视频远程医疗访问。 在此期间,TLC提供者协调和管理药物,提供教育和联系, 社区资源,并促进必要的后续行动。本建议旨在测试薄层色谱法对 再入院率、生活质量和患者对护理的满意度。假设TLC将 改善患者在这些领域的治疗效果。为了实现这些目标,将使用 一项比较TLC与常规护理的实用性阶梯楔形随机对照试验, 三级护理肝脏中心。研究完成后,研究者将提供证据, TC在减少急性医疗保健利用、改善生活质量和患者满意度方面的疗效 患有晚期肝病并发症的患者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric Orman其他文献

Eric Orman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric Orman', 18)}}的其他基金

The Cirrhosis Medical Home: A Feasibility Study
肝硬化医疗之家:可行性研究
  • 批准号:
    9978477
  • 财政年份:
    2020
  • 资助金额:
    $ 70.76万
  • 项目类别:
The Cirrhosis Medical Home: A Feasibility Study
肝硬化医疗之家:可行性研究
  • 批准号:
    10202587
  • 财政年份:
    2020
  • 资助金额:
    $ 70.76万
  • 项目类别:
Unplanned Early Readmissions of Hospitalized Patients with Cirrhosis
住院肝硬化患者的意外提前再入院
  • 批准号:
    9353422
  • 财政年份:
    2016
  • 资助金额:
    $ 70.76万
  • 项目类别:
Unplanned Early Readmissions of Hospitalized Patients with Cirrhosis
住院肝硬化患者的意外提前再入院
  • 批准号:
    9767124
  • 财政年份:
    2016
  • 资助金额:
    $ 70.76万
  • 项目类别:
Unplanned Early Readmissions of Hospitalized Patients with Cirrhosis
住院肝硬化患者的意外提前再入院
  • 批准号:
    10384144
  • 财政年份:
    2016
  • 资助金额:
    $ 70.76万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 70.76万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 70.76万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.76万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.76万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 70.76万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.76万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 70.76万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 70.76万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 70.76万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.76万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了